|
HECTD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.362840E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.473600E-02 |
| Normal-vs-Stage2 |
3.258800E-01 |
| Normal-vs-Stage3 |
3.040600E-01 |
| Normal-vs-Stage4 |
8.766400E-01 |
| Stage1-vs-Stage2 |
8.802600E-01 |
| Stage1-vs-Stage3 |
6.159000E-01 |
| Stage1-vs-Stage4 |
3.001800E-02 |
| Stage2-vs-Stage3 |
8.396600E-01 |
| Stage2-vs-Stage4 |
2.665400E-01 |
| Stage3-vs-Stage4 |
2.241400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.679400E-01 |
| Normal-vs-AfricanAmerican |
4.753400E-01 |
| Normal-vs-Asian |
5.078300E-03 |
| Caucasian-vs-AfricanAmerican |
8.155800E-01 |
| Caucasian-vs-Asian |
6.714200E-02 |
| AfricanAmerican-vs-Asian |
4.656400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.481000E-01 |
| Normal-vs-Female |
8.238100E-02 |
| Male-vs-Female |
3.917400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.157000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.018450E-01 |
| Normal-vs-Age(61-80Yrs) |
1.907990E-01 |
| Normal-vs-Age(81-100Yrs) |
6.786400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.626200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.921600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.014800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.906400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.828100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.426420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.146150E-02 |
| Normal-vs-Grade 2 |
3.335100E-03 |
| Normal-vs-Grade 3 |
7.932600E-01 |
| Normal-vs-Grade 4 |
1.974950E-01 |
| Grade 1-vs-Grade 2 |
4.912200E-01 |
| Grade 1-vs-Grade 3 |
9.303100E-03 |
| Grade 1-vs-Grade 4 |
1.437830E-03 |
| Grade 2-vs-Grade 3 |
6.406500E-04 |
| Grade 2-vs-Grade 4 |
1.95910999999382E-05 |
| Grade 3-vs-Grade 4 |
6.415900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.479760E-02 |
| Normal-vs-ccB subtype |
4.579200E-01 |
| ccA subtype-vs-ccB subtype |
8.576500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.292430E-01 |
| Normal-vs-N1 |
4.274600E-01 |
| N0-vs-N1 |
2.144800E-01 |
|
|
